Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease
Course administration of ultralow doses of antibodies to S-100 protein restores cognitive functions and neurological status, improves emotional state, and reduces anxiety in animals with modeled Alzheimer disease based on cholinergic system defi ciency caused by subchronic treatment with scopolamine...
Gespeichert in:
| Veröffentlicht in: | Bulletin of experimental biology and medicine 2009-09, Vol.148 (3), p.533-535 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 535 |
|---|---|
| container_issue | 3 |
| container_start_page | 533 |
| container_title | Bulletin of experimental biology and medicine |
| container_volume | 148 |
| creator | Voronina, T. A Belopol'skaya, M. V Kheyfets, I. A Dugina, Yu. L Sergeeva, S. A Epshtein, O. I |
| description | Course administration of ultralow doses of antibodies to S-100 protein restores cognitive functions and neurological status, improves emotional state, and reduces anxiety in animals with modeled Alzheimer disease based on cholinergic system defi ciency caused by subchronic treatment with scopolamine. |
| doi_str_mv | 10.1007/s10517-010-0757-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733890578</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1964614931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-2e95abd8bb9b46b603a0a1e8a716b33d919ad26cefdf7d174df5b146c9cb855e3</originalsourceid><addsrcrecordid>eNp9kc9uEzEQxi0EomnhAbiAxYXTgr3eP_YxSlOoVAFSyNmy17Opq1072N6W8IB9LrxNAYkDkiVrxr_5ZsYfQq8oeU8JaT9ESmraFoSSgrR1WxyeoAWtW1bwsqRP0YJkqKg45yfoNMabOSQNfY5OSsJE0zK2QPfrvocuYd_j7ZCCGvwdPvcR4pxZumS1NzZHyeNNkZvir8EnsA7ns3R2VEPEdzZd48txr2wAg1d-52yyt4AvJtcl6x1WzuBzG9MUdAbWo5-zanjIf4Yp-MHvbJcTm6TSFPHkDIQs5IydyYdZ1j_2EOwILmVuOfy8hhyEWRZUhBfoWZ9HgZeP9xnaXqy_rT4VV18-Xq6WV0XHRJWKEkSttOFaC101uiFMEUWBq5Y2mjEjqFCmbDroTd8a2lamrzWtmk50mtc1sDP07qi7D_77BDHJ0cYOhkE58FOU-U-5IHXLM_n2H_LGTyFvHWVJWU2IqEWG6BHqgo8xQC_3eUcVDpISOVssjxbLbLGcLZaHXPP6UXjSI5g_Fb89zUB5BGJ-cjsIfzv_T_XNsahXXqpdsFFuNyWhjFBOGGEV-wUjBr6l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213500959</pqid></control><display><type>article</type><title>Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Voronina, T. A ; Belopol'skaya, M. V ; Kheyfets, I. A ; Dugina, Yu. L ; Sergeeva, S. A ; Epshtein, O. I</creator><creatorcontrib>Voronina, T. A ; Belopol'skaya, M. V ; Kheyfets, I. A ; Dugina, Yu. L ; Sergeeva, S. A ; Epshtein, O. I</creatorcontrib><description>Course administration of ultralow doses of antibodies to S-100 protein restores cognitive functions and neurological status, improves emotional state, and reduces anxiety in animals with modeled Alzheimer disease based on cholinergic system defi ciency caused by subchronic treatment with scopolamine.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-010-0757-y</identifier><identifier>PMID: 20396733</identifier><identifier>CODEN: BEXBAN</identifier><language>eng</language><publisher>Boston: Boston : Springer US</publisher><subject>Alzheimer disease ; Alzheimer Disease - drug therapy ; Alzheimer Disease - pathology ; Animals ; Antibodies - immunology ; Antibodies - therapeutic use ; Anxiety - drug therapy ; Avoidance Learning - drug effects ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Cognition - drug effects ; Cognition Disorders - drug therapy ; Internal Medicine ; Laboratory Medicine ; Male ; Neuropsychological Tests ; Pathology ; Rats ; S-100 protein ; S100 Proteins - immunology ; scopolamine ; Scopolamine - therapeutic use ; ultralow doses</subject><ispartof>Bulletin of experimental biology and medicine, 2009-09, Vol.148 (3), p.533-535</ispartof><rights>Springer Science+Business Media, Inc. 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-2e95abd8bb9b46b603a0a1e8a716b33d919ad26cefdf7d174df5b146c9cb855e3</citedby><cites>FETCH-LOGICAL-c394t-2e95abd8bb9b46b603a0a1e8a716b33d919ad26cefdf7d174df5b146c9cb855e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10517-010-0757-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10517-010-0757-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20396733$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Voronina, T. A</creatorcontrib><creatorcontrib>Belopol'skaya, M. V</creatorcontrib><creatorcontrib>Kheyfets, I. A</creatorcontrib><creatorcontrib>Dugina, Yu. L</creatorcontrib><creatorcontrib>Sergeeva, S. A</creatorcontrib><creatorcontrib>Epshtein, O. I</creatorcontrib><title>Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>Course administration of ultralow doses of antibodies to S-100 protein restores cognitive functions and neurological status, improves emotional state, and reduces anxiety in animals with modeled Alzheimer disease based on cholinergic system defi ciency caused by subchronic treatment with scopolamine.</description><subject>Alzheimer disease</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Alzheimer Disease - pathology</subject><subject>Animals</subject><subject>Antibodies - immunology</subject><subject>Antibodies - therapeutic use</subject><subject>Anxiety - drug therapy</subject><subject>Avoidance Learning - drug effects</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Cognition - drug effects</subject><subject>Cognition Disorders - drug therapy</subject><subject>Internal Medicine</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Neuropsychological Tests</subject><subject>Pathology</subject><subject>Rats</subject><subject>S-100 protein</subject><subject>S100 Proteins - immunology</subject><subject>scopolamine</subject><subject>Scopolamine - therapeutic use</subject><subject>ultralow doses</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc9uEzEQxi0EomnhAbiAxYXTgr3eP_YxSlOoVAFSyNmy17Opq1072N6W8IB9LrxNAYkDkiVrxr_5ZsYfQq8oeU8JaT9ESmraFoSSgrR1WxyeoAWtW1bwsqRP0YJkqKg45yfoNMabOSQNfY5OSsJE0zK2QPfrvocuYd_j7ZCCGvwdPvcR4pxZumS1NzZHyeNNkZvir8EnsA7ns3R2VEPEdzZd48txr2wAg1d-52yyt4AvJtcl6x1WzuBzG9MUdAbWo5-zanjIf4Yp-MHvbJcTm6TSFPHkDIQs5IydyYdZ1j_2EOwILmVuOfy8hhyEWRZUhBfoWZ9HgZeP9xnaXqy_rT4VV18-Xq6WV0XHRJWKEkSttOFaC101uiFMEUWBq5Y2mjEjqFCmbDroTd8a2lamrzWtmk50mtc1sDP07qi7D_77BDHJ0cYOhkE58FOU-U-5IHXLM_n2H_LGTyFvHWVJWU2IqEWG6BHqgo8xQC_3eUcVDpISOVssjxbLbLGcLZaHXPP6UXjSI5g_Fb89zUB5BGJ-cjsIfzv_T_XNsahXXqpdsFFuNyWhjFBOGGEV-wUjBr6l</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Voronina, T. A</creator><creator>Belopol'skaya, M. V</creator><creator>Kheyfets, I. A</creator><creator>Dugina, Yu. L</creator><creator>Sergeeva, S. A</creator><creator>Epshtein, O. I</creator><general>Boston : Springer US</general><general>Springer US</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20090901</creationdate><title>Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease</title><author>Voronina, T. A ; Belopol'skaya, M. V ; Kheyfets, I. A ; Dugina, Yu. L ; Sergeeva, S. A ; Epshtein, O. I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-2e95abd8bb9b46b603a0a1e8a716b33d919ad26cefdf7d174df5b146c9cb855e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Alzheimer disease</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Alzheimer Disease - pathology</topic><topic>Animals</topic><topic>Antibodies - immunology</topic><topic>Antibodies - therapeutic use</topic><topic>Anxiety - drug therapy</topic><topic>Avoidance Learning - drug effects</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Cognition - drug effects</topic><topic>Cognition Disorders - drug therapy</topic><topic>Internal Medicine</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Neuropsychological Tests</topic><topic>Pathology</topic><topic>Rats</topic><topic>S-100 protein</topic><topic>S100 Proteins - immunology</topic><topic>scopolamine</topic><topic>Scopolamine - therapeutic use</topic><topic>ultralow doses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Voronina, T. A</creatorcontrib><creatorcontrib>Belopol'skaya, M. V</creatorcontrib><creatorcontrib>Kheyfets, I. A</creatorcontrib><creatorcontrib>Dugina, Yu. L</creatorcontrib><creatorcontrib>Sergeeva, S. A</creatorcontrib><creatorcontrib>Epshtein, O. I</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Voronina, T. A</au><au>Belopol'skaya, M. V</au><au>Kheyfets, I. A</au><au>Dugina, Yu. L</au><au>Sergeeva, S. A</au><au>Epshtein, O. I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>148</volume><issue>3</issue><spage>533</spage><epage>535</epage><pages>533-535</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><coden>BEXBAN</coden><abstract>Course administration of ultralow doses of antibodies to S-100 protein restores cognitive functions and neurological status, improves emotional state, and reduces anxiety in animals with modeled Alzheimer disease based on cholinergic system defi ciency caused by subchronic treatment with scopolamine.</abstract><cop>Boston</cop><pub>Boston : Springer US</pub><pmid>20396733</pmid><doi>10.1007/s10517-010-0757-y</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-4888 |
| ispartof | Bulletin of experimental biology and medicine, 2009-09, Vol.148 (3), p.533-535 |
| issn | 0007-4888 1573-8221 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733890578 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Alzheimer disease Alzheimer Disease - drug therapy Alzheimer Disease - pathology Animals Antibodies - immunology Antibodies - therapeutic use Anxiety - drug therapy Avoidance Learning - drug effects Biomedical and Life Sciences Biomedicine Cell Biology Cognition - drug effects Cognition Disorders - drug therapy Internal Medicine Laboratory Medicine Male Neuropsychological Tests Pathology Rats S-100 protein S100 Proteins - immunology scopolamine Scopolamine - therapeutic use ultralow doses |
| title | Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A00%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Ultralow%20Doses%20of%20Antibodies%20to%20S-100%20Protein%20in%20Animals%20with%20Impaired%20Cognitive%20Function%20and%20Disturbed%20Emotional%20and%20Neurological%20Status%20under%20Conditions%20of%20Experimental%20Alzheimer%20Disease&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Voronina,%20T.%20A&rft.date=2009-09-01&rft.volume=148&rft.issue=3&rft.spage=533&rft.epage=535&rft.pages=533-535&rft.issn=0007-4888&rft.eissn=1573-8221&rft.coden=BEXBAN&rft_id=info:doi/10.1007/s10517-010-0757-y&rft_dat=%3Cproquest_cross%3E1964614931%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213500959&rft_id=info:pmid/20396733&rfr_iscdi=true |